Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.49
-0.54 (-2.84%)
Nov 16, 2026, 4:00 PM EST - Market closed
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year. That makes Innoviva the 28,441st largest employer in the world and 3,578th in the United States.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,756,717
Profits / Employee
$1,216,604
Market Cap
1.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 159 | 32 | 25.20% |
| Dec 31, 2024 | 127 | 15 | 13.39% |
| Dec 31, 2023 | 112 | 11 | 10.89% |
| Dec 31, 2022 | 101 | 96 | 1,920.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| MannKind | 592 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 310 |
| Structure Therapeutics | 281 |
| Absci | 140 |
| Taysha Gene Therapies | 99 |
| Mineralys Therapeutics | 76 |
INVA News
- 11 days ago - Innoviva price target lowered to $34 from $35 at Oppenheimer - TheFly
- 12 days ago - Innoviva reports Q3 EPS ($1.03) vs. $1.08 last year - TheFly
- 12 days ago - Innoviva Reports Third Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire
- 12 days ago - Innoviva Earnings release: Q3 2026 - Filings
- 12 days ago - Innoviva Quarterly report: Q3 2026 - Filings
- 4 weeks ago - Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026 - Business Wire
- 6 weeks ago - Russian plague outbreak could boost these under-the-radar pharma stocks - Invezz
- 7 weeks ago - Innoviva assumed with an Outperform at Oppenheimer - TheFly